Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Correlation between JAK2-V617F mutations and variation of peripheral blood cells among BCR/ABL-negative MPD patients].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics - 1 Oct 2012

Ye Yuan-xin, Song Xing-bo, Zhou Yi, Ying Bin-wu, Lu Xiao-jun

Abstract excerpt

OBJECTIVE: To assess the correlation between JAK2-V617F mutation and complete blood counts among patients with BCR/ABL-negative myeloproliferative diseases (MPD). METHODS: One hundred and ninety one patients were recruited. Retrospectively, their laboratory data were analyzed for the counts of red blood cells (RBC), white blood cells (WBC) and platelets (PLT). And the incidence of JAK2-V617F mutation was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Fusion Proteins, bcr-abl

Share to Janus Kinase 2

Share to Mutation

Share to Myeloproliferative Disorders

Source

Identifiers

PMID: 23042399
DOI: 10.3760/cma.j.issn.1003-9406.2012.05.018

Genes

JAK2
BCR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Correlation between JAK2-V617F mutations and variation of peripheral blood cells among BCR/ABL-negative MPD patients].PMID 23042399Read ↗

[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].Semantic proximity Read ↗

[Investigation of Laboratory and Clinical Feature in the Patients with Myeloproliferative Neoplasm Co-expression of BCR-ABL1 and JAK2 V617F].Semantic proximity Read ↗

[The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms].Semantic proximity Read ↗

[JAK2 V617F and exon 12 genetic variations in Korean patients with BCR/ABL1-negative myeloproliferative neoplasms].Semantic proximity Read ↗

[Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].Semantic proximity Read ↗

[Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].Semantic proximity Read ↗

[JAK2 V617F mutation burden and its clinical implications in 415 patients with myeloproliferative neoplasm].Semantic proximity Read ↗

Correlations of JAK2–V617F mutation with clinical and laboratory findings in patients with myeloproliferative disordersSemantic proximity Read ↗

Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts.Semantic proximity Read ↗

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.Semantic proximity Read ↗

Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.Semantic proximity Read ↗

[JAK2V617F mutation and p-STAT5 protein expression in peripheral blood cells of patients with myeloproliferative neoplasm and their relations with clinical features].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.